Top news of the week: 06.10.2020.
#biotechnology #lifesciences #pharmaceuticals #biospace #clinicaltrials #pandemic #treatment #vaccine #COVID19 #coronavirus
Companies And Industries
We thank all the panelists and participants.
Join us for upcoming session at- https://t.co/8qWTuSH9CY
Registrations will be open soon.
@BIRAC_2012 @DBTIndia @moefcc @CPCB_OFFICIAL @startupindia @makeinindia @drskavita https://t.co/x6TwZavptt
OpenBiosafety and Biocontainment Requirements for Biopharma Research and Manufacturing
This is the home page's excerpt
Perlmutter, who just this week joined the board of AI biotech Insitro, “will remain as a non-executive director, MRL through June 2o21, to facilitate a seamless transition,” according to a statement from Merck. https://t.co/ECl2l9eWZb $MRK
OpenPerlmutter steps down as Merck R&D lead as early research chief Li steps in
After seven years running Merck’s R&D engine, much of which has revolved around cancer blockbuster Keytruda and, now, COVID-19 vaccines, Roger Perlmutter, M.D., Ph.D., is hitting the exit.
European biotech raises $4.8B in record-breaking quarter
DUBLIN – In what continues to be a year like no other, European biotechnology firms engaged in drug development raised $4.783 billion in equity financing during the third quarter. It is an ...
With a Lasting Legacy, Merck's R&D Chief to Retire Effective Jan. 1
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/uF0VEAbw3w
OpenWith a Lasting Legacy, Merck's R&D Chief to Retire Effective Jan. 1
Merck announced that Roger M. Perlmutter, the company’s executive vice president and president of Merck Research Laboratories, was retiring effective January 1, 2021. He will be succeeded ...
BridgeBio’s treatment is based on a genetic variant that prevents some people with the disease-causing gene from getting sick. https://t.co/8vEDaazjmd
OpenBridgeBio's en route to proving out its 'Moneyball' for biotech model: CEO
When Neil Kumar, Ph.D., started BridgeBio Pharma in 2015, he met a lot of rejection. Investor after investor passed on his idea: picking up rare disease treatments “lying fallow” in ...
@nkakaroubas @WomenScienceRFS @matthewcobb Hi Nick. It will definitely be available on demand after the live broadcast, if you are not available 8 am PT, 11 am ET, or 17:00 CET. We will share the link if anyone misses it. You can also listen to our on-demand or check out upcoming webinars here: https://t.co/D9J15WEZvn
OpenGEN – Genetic Engineering and Biotechnology News
In this GEN webinar, sponsored by Horizon Discovery, , we will hear from the experiences of two scientists working in different departments at Jounce Therapeutics that have …
Biopharma Update on the Novel Coronavirus: October 2
#biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/19yWn4PYTU
OpenBiopharma Update on the Novel Coronavirus: October 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
Biopharma Update on the Novel Coronavirus: September 30
#biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/j5R9diau7E
OpenBiopharma Update on the Novel Coronavirus: September 30
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 30, 2020.